-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
-
Summary
-
Oyster Point Pharma, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from 2020 to 2021.
- Oyster Point Pharma, Inc. Selling and Marketing Expense for the quarter ending September 30, 2022 was $22.1M, a 21.6% increase year-over-year.
- Oyster Point Pharma, Inc. Selling and Marketing Expense for the twelve months ending September 30, 2022 was $103M.
- Oyster Point Pharma, Inc. annual Selling and Marketing Expense for 2021 was $54.6M, a 453% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Annual (USD)
Selling and Marketing Expense, YoY Annual Growth (%)